Comparison between Aritas Vinyl IPO and GNH India Pharmaceuticals IPO.
Aritas Vinyl IPO is a SME Bookbuilding IPO proposed to list at BSE SME while GNH India Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Aritas Vinyl IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Aritas Vinyl IPO is up to ₹35.63 Cr whereas the issue size of the GNH India Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Aritas Vinyl IPO is ₹47.00 per share and of GNH India Pharmaceuticals IPO is .
| Aritas Vinyl IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹40.00 per share | |
| Issue Price (Upper) | ₹47.00 per share | |
| Issue Price (Final) | ₹47.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | |
| Fresh Issue Size | 65,96,600 shares | 37,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹31.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 9,84,400 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹4.63 Cr | up to ₹0.00 Cr |
| Issue Size Total | 75,81,000 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹35.63 Cr | up to ₹0.00 Cr |
Aritas Vinyl IPO opens on Jan 16, 2026, while GNH India Pharmaceuticals IPO opens on . The closing date of Aritas Vinyl IPO and GNH India Pharmaceuticals IPO is Jan 20, 2026, and , respectively.
| Aritas Vinyl IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 16, 2026 | |
| Issue Close | Jan 20, 2026 | |
| Basis Of Allotment (Tentative) | Jan 21, 2026 | |
| Initiation of Refunds (Tentative) | Jan 22, 2026 | |
| Credit of Share (Tentative) | Jan 22, 2026 | |
| Listing date (Tentative) | Jan 23, 2026 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Aritas Vinyl IPO P/E ratio is 14.43, as compared to GNH India Pharmaceuticals IPO P/E ratio of .
| Aritas Vinyl IPO | GNH India Pharmaceuticals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 47.22 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 27.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹92.54 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 31.23 | 22.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.99 | 21.49 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.36 | 16.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aritas Vinyl IPO Retail Individual Investors (RII) are offered 45,12,000 shares while in GNH India Pharmaceuticals IPO retail investors are offered 45,12,000 shares. Qualified Institutional Buyers (QIB) are offered 78,000 shares in Aritas Vinyl IPO and in GNH India Pharmaceuticals IPO.
| Aritas Vinyl IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 4,02,000 shares | |
| QIB | 78,000 shares | |
| NII | 29,91,000 shares | |
| RII | 45,12,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 75,81,000 shares |
Aritas Vinyl IPO subscribed 2.21x in total, whereas GNH India Pharmaceuticals IPO subscribed .
| Aritas Vinyl IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 1.00x | |
| NII (times) | 1.24x | |
| Big NII (times) | 1.28x | |
| Small NII (times) | 1.15x | |
| RII (times) | 2.88x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.21x |
